Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COMPASS Pathways plc (NASDAQ:CMPS – Get Rating) – Investment analysts at Oppenheimer dropped their FY2022 earnings per share estimates for shares of COMPASS Pathways in a research report issued to clients and investors on Wednesday, October 12th. Oppenheimer analyst F. Brisebois now anticipates that the company will post earnings per share of ($2.25) for the […]
One way to compete with big generalist funds is to create exactly the opposite thing.
First ever phase 3 program of psilocybin therapy globally scheduled to begin in 2022...
Decades of biological research haven't improved diagnosis or treatment. We should look to society, not to the brain.
Clerkenwell Health a psychedelic-specialist clinical research organisation, has raised £2.1m in seed funding, bringing the total to date up to £2.5m, which will be used to get the London startup-based fully operational.